Header Logo

Connection

Mayer Davidson to Enalapril

Back to Details
This is a "connection" page, showing publications Mayer Davidson has written about Enalapril.
Mayer Davidson
Connection Strength
0.202
Enalapril
  1. Angiotensin-converting enzyme inhibition for the treatment of moderate to severe diabetic retinopathy in normotensive Type 2 diabetic patients. A pilot study. J Diabetes Complications. 2002 Nov-Dec; 16(6):377-81.
    View in: PubMed
    Score: 0.202
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.